Roy Moscona

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Gene Expression

Top Venues

Pigment cell & melanoma research

Cell death discovery

Ben-Gurion University of the Negev

Ben-Gurion University of the Negev (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ben-Gurion University of the Negev

Israel

Teacher Assistant :: Medical Health

Israel Ministry of Health

Israel

Research Assistant :: Central Virology Laboratory, Sheba-Medical Center

Education History

Ben-Gurion University of the Negev

Israel

PHD :: The Shraga Segal Department of Microbiology, Immunology and Genetics

Tel Aviv University

Israel

MSC :: The Miriam and Sheldon Edelson school of graduate degrees , Sakler school of Medicine

Bar-Ilan University

Israel

BSC :: The Mina & Everard Goodman Faculty of Life Sciences

Publications

Roy Moscona, Sanne Marlijn Janssen, Mounib Elchebly, Andreas Ioannis Papadakis, Eitan Rubin, Alan Spatz
BORIS/CTCFL-mediated chromatin accessibility alterations promote a pro-invasive transcriptional signature in melanoma cells. Pigment cell & melanoma research (2023)
Roy Moscona, Sanne Marlijn Janssen, Mounib Elchebly, Andreas Ioannis Papadakis, Eitan Rubin, Alan Spatz
BORIS/CTCFL-mediated chromatin accessibility alterations promote a pro-invasive transcriptional signature in melanoma cells. Pigment cell & melanoma research (2023)
Roy Moscona, Sanne Marlijn Janssen, Mounib Elchebly, Andreas Ioannis Papadakis, Eitan Rubin, Alan Spatz
BORIS/CTCFL-mediated chromatin accessibility alterations promote a pro-invasive transcriptional signature in melanoma cells. Pigment cell & melanoma research (2023)
Sanne Marlijn Janssen, Roy Moscona, Mounib Elchebly, Andreas Ioannis Papadakis, Margaret Redpath, Hangjun Wang, Eitan Rubin, Léon Cornelis van Kempen, Alan Spatz
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells. Cell death discovery 6 (2020)